U.S. markets closed

AquaBounty Technologies, Inc. (AQB)

NasdaqCM - NasdaqCM Real Time Price. Currency in USD
Add to watchlist
1.4300-0.1100 (-7.14%)
At close: 04:00PM EDT
1.4800 +0.05 (+3.50%)
After hours: 07:59PM EDT
Full screen
Trade prices are not sourced from all markets
Gain actionable insight from technical analysis on financial instruments, to help optimize your trading strategies
Chart Events
Bearishpattern detected
Price Crosses Moving Average

Price Crosses Moving Average

Previous Close1.5400
Bid1.4500 x 900
Ask1.4500 x 1400
Day's Range1.4200 - 1.5700
52 Week Range1.1300 - 4.9900
Avg. Volume715,966
Market Cap101.687M
Beta (5Y Monthly)0.94
PE Ratio (TTM)N/A
EPS (TTM)-0.3280
Earnings DateNov 02, 2022 - Nov 07, 2022
Forward Dividend & YieldN/A (N/A)
Ex-Dividend DateN/A
1y Target Est5.13
Fair Value is the appropriate price for the shares of a company, based on its earnings and growth rate also interpreted as when P/E Ratio = Growth Rate. Estimated return represents the projected annual return you might expect after purchasing shares in the company and holding them over the default time horizon of 5 years, based on the EPS growth rate that we have projected.
Fair Value

Subscribe to Yahoo Finance Plus to view Fair Value for AQB

View details
Research that delivers an independent perspective, consistent methodology and actionable insight
Related Research
  • AquaBounty Technologies, Inc.
    Analyst Report: Charles River Laboratories International, Inc.Charles River Laboratories was founded in 1947 and is a leading provider of drug discovery and development services. The company’s research model & services segment is the leading provider of animal models for laboratory testing, which breeds and delivers animal research models with specific genetic characteristics for preclinical studies around the world. The discovery & safety assessment segment includes services required to take a drug through the early development process, including discovery services. The manufacturing support segment includes microbial solutions, which provides in vitro (non-animal) testing products, biologics testing services, and avian vaccine services.
    Fair Value
    Economic Moat
    8 days agoMorningstar
View more
  • GlobeNewswire

    AquaBounty Technologies, Inc. Announces Second Quarter 2022 Financial Results

    MAYNARD, Mass., Aug. 09, 2022 (GLOBE NEWSWIRE) -- AquaBounty Technologies, Inc. (NASDAQ: AQB) (“AquaBounty” or the “Company”), a land-based aquaculture company utilizing technology to enhance productivity and sustainability, today announced the Company’s financial results for the second quarter ended June 30, 2022. Second Quarter 2022 Highlights and Recent Developments Generated $1.1 million in product revenue in the second quarter, a year-over-year increase of 371% as compared to $227 thousand

  • Simply Wall St.

    Do Institutions Own AquaBounty Technologies, Inc. (NASDAQ:AQB) Shares?

    If you want to know who really controls AquaBounty Technologies, Inc. ( NASDAQ:AQB ), then you'll have to look at the...

  • GlobeNewswire

    Proxy Advisory Firm ISS Recommends Vote “FOR” the Charter Amendment Proposal – To Increase the Number of Authorized Shares of Common Stock

    MAYNARD, Mass., May 20, 2022 (GLOBE NEWSWIRE) -- AquaBounty Technologies, Inc. (NASDAQ: AQB) (“AquaBounty” or the “Company”), a land-based aquaculture company utilizing technology to enhance productivity and sustainability, today announced that leading proxy advisory firm Institutional Shareholder Services Inc. (ISS), in addition to the Company’s Board of Directors and proxy advisory firm Glass Lewis, has recommended that the Company’s stockholders vote in favor of the proposal to amend the Comp